Top Abstract Purchase Related
Home
>
Node
>
Subnode

Chronic obstructive pulmonary disease and coronary heart disease: approaches to the treatment of combined pathology

Bova, A.A.; Lapitskiĭ, D.V.

Klinicheskaia Meditsina 87(2): 8-13

2009

ISSN/ISBN: 0023-2149
PMID: 19348292
Document Number: 628531
This review concerns peculiarities of pharmacotherapy for patients with concomitant coronary heart disease and chronic obstructive pulmonary disease. It describes the main pharmacodynamic and pharmacokinetic properties of cholinolytics, beta-agonists, methylxanthines, corticosteroids, antibiotics, ACE inhibitors, calcium channel blockers, beta-blockers, nitrates, and anti-aggregants. These data are used to substantiate the application of these drugs to the treatment of overlapping pathologies with special reference to concomitant coronary heart disease and chronic obstructive pulmonary disease.

Document emailed within 1 workday
Secure & encrypted payments

Shoĭkhet, I.N.; Klester, E.B. 2010: Digestive system pathology in patients with chronic obstructive pulmonary disease concurrent with coronary heart disease Terapevticheskii Arkhiv 82(2): 25-28
Zhdan, V.; Khaymenova, G.; Shilkina, L.; Martynyuk, D.; Babanina, M.; Mamontova, T. 2017: Determine the effectiveness of lipid-lowering therapy in patients with chronic obstructive pulmonary disease combined with coronary heart disease Wiadomosci Lekarskie 70(2 Part 2): 303-305
Akhmineeva, A.K. 2014: Biochemical markers of endothelial dysfunction in chronic obstructive pulmonary disease concurrent with hypertensive disease or coronary heart disease Terapevticheskii Arkhiv 86(3): 20-23
Shoĭkhet, I.N.; Klester, E.B.; Golovin, V.A. 2008: Heart rhythm disturbances in patients with chronic obstructive pulmonary disease in aggregate with coronary heart disease Klinicheskaia Meditsina 86(3): 21-26
Provotorov, V.M.; Budnevskiĭ, A.V.; Semenkova, G.G.; Shishkina, E.S. 2015: Proinflammatory Cytokines in Combination of Coronary Heart Disease and Chronic Obstructive Pulmonary Disease Klinicheskaia Meditsina 93(2): 5-9
Zunnunov, Z.R. 2010: The clinical efficiency and safety of iodide-bromine balneotherapy in patients with coronary heart disease concurrent with chronic obstructive pulmonary disease Terapevticheskii Arkhiv 82(1): 24-27
Pribylov, S.A. 2006: Pulmonary hypertension, endothelial dysfunction, and their correction with lisinopril in patients with heart failure in combination of ischemic heart disease and chronic obstructive pulmonary disease Kardiologiia 46(9): 36-40
Karoli, N.A.; Rebrov, A.P. 2005: Chronic obstructive lung disease and coronary heart disease Klinicheskaia Meditsina 83(6): 72-76
Sinopal'nikov, A.I.; Guchev, I.A. 2002: Exacerbation of chronic obstructive pulmonary disease: current approaches to antibacterial therapy Klinicheskaia Meditsina 80(6): 57-62
Sang, X.-h.; Yan, S.-f.; Sun, Y. 2012: The prevalence and risk factors of coronary heart disease combined with chronic kidney disease Zhonghua Nei Ke Za Zhi 51(2): 123-126
Zhelezniakova, N. 2013: Formation of immune distress syndrome in patients with combined course of chronic obstructive pulmonary disease and chronic pancreatitis Georgian Medical News 214: 19-23
Mangelsdorff, G.; Borzone, G.; Leiva, A.; Martínez, A.; Lisboa, C. 2001: Strength of inspiratory muscles in chronic heart failure and chronic pulmonary obstructive disease Revista Medica de Chile 129(1): 51-59
Volchkova, E.A.; Zateĭshchikova, A.A.; Shavrin, I.V.; Kiselev, D.G.; Brazhnik, V.A.; Privalov, D.V.; Doshchitsin, V.L.; Zateĭshchikov, D.A. 2012: Association of parameters of heart rate variability with severity of bronchial obstruction and presence of pulmonary hypertension in patients with chronic obstructive pulmonary disease Kardiologiia 52(7): 42-49
Zafiraki, V.K.; Namitokov, A.M.; Kosmacheva, E.D.; Shulzhenko, L.V.; Omarov, A.A.; Ramazanov, J.M.; Pershukov, I.V. 2016: Changing Clinical Presentation of Acute Coronary Syndrome in Patients With Chronic Obstructive Pulmonary Disease Kardiologiia 56(5): 30-36
Demikhova, O.V.; Degtiareva, S.A. 2001: New aspects of combined therapy of chronic pulmonary heart disease Problemy Tuberkuleza 7: 40-42
Nici, L.; Lareau, S.; ZuWallack, R. 2010: Pulmonary rehabilitation in the treatment of chronic obstructive pulmonary disease American Family Physician 82(6): 655-660
Fernández-Fernández, F.J.; Ameneiros-Lago, E.; González Moraleja, J.; Pía Iglesias, G.; Martínez-Debén, F.S.; Sesma, P. 2003: Treatment of chronic obstructive pulmonary disease Anales de Medicina Interna 20(3): 148-155
Tschopp, J.M.; Gabathuler, J.; Righetti, A.; Junod, A.F. 1985: Comparative effects of acute O2 breathing and terbutaline in patients with chronic obstructive pulmonary disease. a combined hemodynamic and radionuclide study European Journal of Respiratory Diseases 67(5): 351-359
Lampert, E.; Tuo, N.; Frans, A.; Lonsdorfer, J. 1991: Disappearance of molsidomine effects on pulmonary circulation of patients with chronic obstructive pulmonary disease after a three week treatment Pathologie-Biologie 39(1): 29-33
Titova, O.N.; Ignat'ev, V.A.; Didur, M.D.; Kameneva, M.Iu.; Sukhovskaia, O.A. 2008: Combination of thiotropium bromide with almitrine and pulmonary rehabilitation in the treatment of patients with chronic obstructive pulmonary disease Terapevticheskii Arkhiv 80(3): 28-33